Content
Joint Statement and Recommendations on Vitamin K Administration to Newborn Infants to Prevent Vitamin K Deficiency Bleeding in Infancy
Published year: 2000 |
Reference No: CH39 |
Download publication:
» Download: Joint Statement and Recommendations on Vitamin K Administration to Newborn Infants to Prevent Vitamin K Deficiency Bleeding in Infancy (PDF, 80kb)
» HTML: Joint Statement and Recommendations on Vitamin K Administration to Newborn Infants to Prevent Vitamin K Deficiency Bleeding in Infancy
Synopsis of publication:
The NHMRC has issued guidelines in the form of the Joint statement and recommendations on vitamin K administration to newborn infants to prevent vitamin K deficiency bleeding in infancy to newborns. New guidelines are issued following Roche Australia's decision to alter the vitamin K preparation Konakion to a new formulation called Konakion MM Paediatric. The new product is manufactured in a different concentration and is dissolved in more natural fluid that assists absorption.
The guidelines recommend that all newborn infants should receive vitamin K prophylaxisand receive an intramuscular injection of 1mg (0.1ml) of Konakion MM at birth.
The guidelines also recommend that parents receive written information during the antenatal period about the importance of vitamin K, and the options of intramuscular or oral treatments.
Vitamin K for Newborn Babies - Information for Parents (Cat. No. 0141606)
To find other publications use the subject list or the search
Help
|
|
Linked documents tagged with the PDF icon Note: Attempting to open large PDF files within the browser window may lead to system problems. For more information see Troubleshooting and access of large pdf documents. |